Moniruzzaman A, Elwood R K, Schulzer M, FitzGerald J M
Department of Health Care and Epidemiology, University of British Columbia, Vancouver, Canada.
Int J Tuberc Lung Dis. 2006 Jun;10(6):631-8.
Provincial tuberculosis (TB) services, British Columbia, Canada.
To investigate risk factors associated with resistance to anti-tuberculosis drugs in British Columbia and to determine if there are differences in risk factor characteristics among different resistance categories.
Using population-based data from provincial TB services, all patients with positive culture for Mycobacterium tuberculosis from 1990 to 2001 were identified and included in the study. Logistic regression analyses were performed to assess risk factors for drug resistance.
Among 3041 eligible TB cases, 295 (10%) were found to be drug-resistant. Significant risk factors for resistance were younger age, foreign birth, ethnicity, reactivated TB and place of initial diagnosis. Foreign-born subjects (OR 3.18, 95%CI 2.26-4.49) were three times more likely to present with resistance than Canadian-born subjects. Among ethnic groups, Chinese (OR 2.32, 95%CI 1.51-3.57), South-East Asian (OR 2.92, 95%CI 1.88-4.52) and Other Asian subjects (OR 4.40, 95%CI 2.77-7.01) were 2-4 times more likely to present with resistance than Caucasians. Reactivated cases (OR 2.69, 95%CI 1.91-3.77) were three times as likely to have resistance as new cases.
These results document and quantify the risk of drug-resistant disease in a large population-based cohort, and highlight patient groups who should be identified as at risk for drug-resistant disease in the industrialised world.
加拿大不列颠哥伦比亚省省级结核病防治机构。
调查不列颠哥伦比亚省耐抗结核药物的相关危险因素,并确定不同耐药类别之间危险因素特征是否存在差异。
利用省级结核病防治机构基于人群的数据,确定并纳入1990年至2001年间所有结核分枝杆菌培养阳性的患者。进行逻辑回归分析以评估耐药危险因素。
在3041例符合条件的结核病病例中,发现295例(10%)耐药。耐药的显著危险因素包括年龄较小、出生于国外、种族、复发性结核病和初次诊断地点。出生于国外的受试者(比值比3.18,95%置信区间2.26 - 4.49)出现耐药的可能性是加拿大出生受试者的三倍。在种族群体中,华裔(比值比2.32,95%置信区间1.51 - 3.57)、东南亚裔(比值比2.92,95%置信区间1.88 - 4.52)和其他亚裔受试者(比值比4.40,95%置信区间2.77 - 7.01)出现耐药的可能性是白种人的2至4倍。复发病例(比值比2.69,95%置信区间1.91 - 3.77)出现耐药的可能性是新发病例的三倍。
这些结果记录并量化了一个大型基于人群队列中耐药疾病的风险,并突出了在工业化国家应被确定为耐药疾病高危人群的患者群体。